The Senate Appropriations Committee unanimously advanced a fiscal 2018 FDA funding bill out of committee Thursday (July 20) that adds $1 million in discretionary funding for FDA over the fiscal 2017 enacted level, totaling $2.8 billion, and adds $60 million in additional funding for the agency to implement the 21st Century Cures Act. The bill does not cut FDA’s discretionary funding, as proposed by President Donald Trump, Senate Appropriations Committee Vice Chair Patrick Leahy (D-VT) noted. “[T]he funding in this...